Search

Search Results

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  3-7

  https://doi.org/10.4081/reumatismo.2005.4s.3

  1415

  PDF: 851

• PO:20:002 | Respiratory function tests predict bone mineral density in autoimmune rheumatic disease patients Andrea Zoli¹, Panagiotis Garantziotis², Sebastian Böltz², Janina Auth², Sara Bayat², Jule Taubmann², Anna-Maria Liphardt², Maria Antonietta D'Agostino¹, Christina Bergmann², Georg Schett². | ¹Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ²Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander Universität FAU, Erlangen, Germany.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2050

  143
• 

  Poncet’s disease diagnostic criteria decodes conundrum: Poncet’s vs pseudo Poncet’s

  V. Shobha, A.M. Desai

  46-50

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1114

  2004

  PDF: 1368
• 

  Sjögren’s syndrome and mean platelet volume

  M. E. Tezcan, Ş. Demir, M. Sargın, M. Aliustaoğlu, B. Göker

  33-34

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.752

  1436

  PDF: 1189
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.185

  1702

  PDF: 1318

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  https://doi.org/10.4081/reumatismo.2008.35

  2101

  PDF: 1610

• PO:06:088 | Are all Difficult-To-Treat RA patients the same? Insights into clinical features and drug discontinuation Silvia Di Noto¹, Cristina Garufi¹, Letizia Caruso¹, Fulvia Ceccarelli¹, Cristiano Alessandri¹, Federica Ucci¹, Valerio Fiorilli¹, Fabrizio Conti¹, Francesca Romana Spinelli¹ | ¹Sapienza University of Rome, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2300

  39

• HAQ-DI Italian version in systemic sclerosis

  G. La Montagna, G. Cuomo, I. Chiarolanza, L. Ruocco, G. Valentini

  112-115

  https://doi.org/10.4081/reumatismo.2006.112

  1709

  PDF: 2069
• 

  From anatomy to therapy: the historical journey to cortisone

  Ernesto Damiani, Piero Marson, Francesco M. Galassi

  19-11-2025

  https://doi.org/10.4081/reumatismo.2025.1935

  2001

  PDF: 49

  SUPPLEMENTARY MATERIAL: 100

• PO:24:066 | Antibody profile in myositis and early risk of interstitial lung disease: clinical and laboratory correlations in patients with suspected rheumatologic disease Lindsay Brooke Boling¹, Gaia Deleonardi², Alarico Ariani³, Tania Silvestri², Ana Gabriela Grondona², Marica Trevisani³, Rita Mulè³, Enrica Vandelli³, Gentiana Vukatana³, Elisa Rossi³, Olga Addimanda³, Francesca Bergossi³, Angela Buffa³, Giovanni B. Canestrari³, Francesco Cianci³, Daniela Chiarini³, Laura Gigante³, Nicolò Girolimetto³, Daniele Lini³, Luca Magnani³, Mirco Magnani³, Erika Meleddu³, Francesca Pignataro³, Sofia Testoni³, Massimo Reta³ | ¹Scuola di Allergologia ed Immunologia Clinica-Università di Bologna; ²LUM Laboratorio Unico Metropolitano - Immunologia Clinica, Ospedale Maggiore, Bologna; ³UO Medicina Interna ad indirizzo reumatologico SC interaziendale - IRCCS AOU, AUSL Bologna, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2187

  161

• PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta¹, Andrew Östör^2|8, Eugen Feist³, Prodromos Sidiropoulos⁴, Jérôme Avouac⁵, Martin Rebella^6|7, Rajaie Namas⁹, Erin Mcdearmon Blondell¹⁰, Ivan Lagunes¹⁰, Tianming Gao¹⁰, Tim Shaw¹⁰, Suzan Attar¹¹ | ¹AbbVie Srl Roma, Italy; ²Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; ³Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; ⁴Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; ⁵Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; ⁶Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; ⁷Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; ⁸Australian National University, Camberra, Australia; ⁹Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; ¹⁰AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; ¹¹King Abdulaziz University, Jeddah, Saudi Arabia

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2306

  22
• 

  Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease

  D. Rincón-Riaño, D.G. Fernández-Ávila, D. Acero-Molina, J.M. Bello Gualtero , C. Romero-Sánchez

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1420

  1790

  PDF: 944
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1064

  2563

  PDF: 1710

• How to prescribe physical exercise in rheumatology

  S. Maddali Bongi, A. Del Rosso

  4-11

  https://doi.org/10.4081/reumatismo.2010.4

  4398

  PDF: 3182
• 

  Observations about subcalcaneal adventitial bursitis (heel fat pad inflammatory lesion) in rheumatoid arthritis. Comment on the article of Suzuki and Shirai

  P. Falsetti, E. Conticini, C. Baldi, C. Acciai, R. D'Alessandro, M. Bardelli, L. Cantarini, B. Frediani

  182-183

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1282

  911

  PDF: 726

• Farmacoeconomic impact of anti-TNFα

  G. Leardini, C. Bernardi, E. Vaccaro

  80-86

  https://doi.org/10.4081/reumatismo.2004.1s.80

  949

  PDF: 697

• Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases

  C. Sales, F. Oliviero, P. Spinella

  95-101

  https://doi.org/10.4081/reumatismo.2008.95

  2863

  PDF: 1915

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  https://doi.org/10.4081/reumatismo.2005.114

  1007

  PDF: 2821

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  https://doi.org/10.4081/reumatismo.2002.324

  1026

  PDF: 2740

• Are there any positive effects of TNF-alpha blockers on bone metabolism?

  B. Seriolo, S. Paolino, A. Sulli, M. Cutolo

  199-205

  https://doi.org/10.4081/reumatismo.2006.199

  1440

  PDF: 1256

• CO:09:3 | Effectiveness and safety of nintedanib in autoimmune systemic diseases: real life data from an Italian multicentre study (Island group) of the Italian Society of Rheumatology Corrado Campochiaro¹, Paola Conigliaro², Gianluca Sambataro³, Marco Matucci-Cerinic¹, Marco Sebastiani⁴, Gianluca Bajocchi⁵, Angelo Fassio⁶, Elena Treppo⁷, Elisabetta Zanatta⁸, Elena Bartolini⁹, Francesco Ferro¹⁰, Chiara Bazzini¹¹, Nicoletta Del Papa¹², Gemma Lepri¹³, Andrea Lo Monaco¹⁴, Marta Favero¹⁵, Annamaria Iuliano¹⁶, Francesca Li Gobbi¹⁷, Maria Sole Chimenti², Giuseppe Muscato¹⁸, Giacomo De Luca¹, Francesca Cozzini⁴, Lucia Dardani⁵, Francesco Pollastri⁶, Alessandro Gattron⁷, Beatrice Moccaldi⁸, Caterina Antonini⁹, Gaetano La Rocca¹⁰, Ilaria Cavazzana¹¹, Andreina Manfredi^5|19. | ¹IRCCS San Raffaele Hospital, Vita-Salute San Raffaele, Milano; ²U.O.C. Reumatologia Dipartimento di Medicina dei Sistemi Università di Roma-Tor Vergata, Roma; ³Università Kore, Enna; ⁴University of Parma, Azienda Ospedaliera di Piacenza; ⁵UOC Reumatologia, AUSL IRCCS Reggio Emilia; ⁶UOC Reumatologia Università degli Studi di Verona; ⁷Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; ⁸UOC Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; ⁹SC Interaziendale di Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia, Azienda Integrata Università; ¹⁰Dipartimento di Medicina Clinica e Sperimentale UO Reumatologia-Universitaria AOU Pisa; ¹¹U.O. Reumatologia e Immunologia Clinica ASST Spedali Civili di Brescia; ¹²Clinica Reumatologica, Milano; ¹³S.O.D. di Reumatologia AOU Careggi, Firenze; ¹⁴UOC Reumatologia Azienda Ospedaliero-Universitaria Sant'Anna, Ferrara; ¹⁵Internal Medicine I, Department of Medicine, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Treviso; ¹⁶UOC Reumatologia, AO San Camillo Forlanini, Roma; ¹⁷Rheumatology Unit, S.Giovanni di Dio Hospital, Firenze; ¹⁸Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico, Catania; ¹⁹Università degli Studi di Modena e Reggio Emilia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1987

  127

• PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni¹, Silvia Sirotti^1|2, Georgios Filippou^1|2, Piercarlo Sarzi Puttini^1|2, Greta Pellegrino^1|2. | ¹Università degli Studi di Milano, Milano; ²IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2028

  142
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  1964

  PDF: 1130

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  https://doi.org/10.4081/reumatismo.2010.253

  2371

  PDF: 905
• 

  Paratenon effusion of the Achilles tendon: a rare finding

  Raphael Micheroli, Vincenzo Ricci, Ondřej Naňka, Giorgio Tamborrini

  01-09-2025

  https://doi.org/10.4081/reumatismo.2025.1845

  1210

  PDF: 124

  SUPPLEMENTARY VIDEO: 134

• PO:12:180 | Echocardiographic screening of pulmonary hypertension in a multidisciplinary cohort of patients with interstitial lung disease Lorenzo Mattia Bianchessi¹, Veronica Piccin¹, Federica Sabatelli¹, Lorenzo Cavagna¹, Giovanni Zanframundo¹, Domenicafederica Briganti², Mauro Acquaro³,  Stefano Ghio³, Domenico Sorace¹, Valentina Vertui², Ilaria Giana², Andrea Patanè³, Veronica Codullo¹ | ¹UOC Reumatologia, Fondazione IRCCS Policlinico S. Matteo, Pavia; ²Centro Trapianti, Fondazione IRCCS Policlinico San Matteo, Pavia; ³UOC Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2156

  152

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  https://doi.org/10.4081/reumatismo.2005.109

  1142

  PDF: 3879
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1222

  2163

  PDF: 955

• PO:12:177 | Systemic inflammation and QTc interval prolongation in new-onset polymyalgia rheumatica: the effect of corticosteroid therapy Anna Colangelo¹, Riccardo Accioli², Viola Salvini², Francesco Tromby¹, Giulia Cruciani¹, Martina Nicchi¹, Biancamaria Pianese¹, Francesca Lalli¹, Anna Cantore², Caterina Antonini¹, Decoroso Verrengia², Andrea Castellucci¹, Giacomo Cafaro¹, Carlo Perricone¹, Roberto Gerli¹, Pietro Enea Lazzerini², Elena Bartoloni¹ | ¹SC Reumatologia. Università di Perugia, Italy; ²Dipartimento di Scienze Mediche, Università di Siena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2313

  36

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  https://doi.org/10.4081/reumatismo.2009.1

  1647

  PDF: 775
• 

  Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and a review of the literature

  E. Yılmaz

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1557

  2633

  PDF: 867

• New classification criteria for rheumatoid arthritis

  C.A. Scirè, R. Caproali

  159-162

  https://doi.org/10.4081/reumatismo.2010.159

  2572

  PDF: 9054

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  https://doi.org/10.4081/reumatismo.2006.50

  1005

  PDF: 2176
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1527

  920

  PDF: 430

• Rheumatic diseases at the court of the Medici of Florence: the so-called “gout” of the Medici

  G. Fornaciari, V. Giuffra

  229-237

  https://doi.org/10.4081/reumatismo.2009.229

  1217

  PDF: 886

• PO:27:106 | Role of histology in interstitial lung involvement of rheumatic diseases in real life scenario Francesca Cozzini^1|2, Francesco Falco¹, Lucia Spaggiari^1|3, Alberto Cavazza¹, Adele Del Giudice^1|2, Lucia Dardani¹, Fabio Brandolino¹, Emanuele Cocchiara¹, Ilaria Chiapparoli¹, Luca Magnani⁴, Gianluigi Bajocchi¹, Carlo Salvarani^1|2, Andreina Manfredi^1|2 | ¹IRCCS Arcispedale Santa Maria Nuova Reggio Emilia, Italy; ²Università degli Studi di Modena e Reggio Emilia Modena, Italy; ³AUSL area NORD Montecchio-Guastalla, Italy; ⁴UOC di Medicina Interna ad Indirizzo Reumatologico, Azienda USL Bologna, Ospedale Maggiore Bologna, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2358

  40

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  https://doi.org/10.4081/reumatismo.2008.50

  2050

  PDF: 1195

• A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

  Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini

  22-25

  https://doi.org/10.4081/reumatismo.2006.22

  1660

  PDF: 2083